# Ibandronate

## Bonviva inj 3mg/3mL

| TAH Drug Code      | [IBONV](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBONV)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of osteoporosis in postmenopausal women.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | 3 mg IV every 3 months.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Uncorrected hypocalcaemia. Severe renal impairment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Back pain， pain in extremity， infection， asthenia， allergic reaction; GI disturbances; hypercholesterolemia; myalgia， joint disorder; arthritis; headache， dizziness， vertigo， nerve root lesion; upper resp infection， bronchitis， pneumonia， pharyngitis; UTI. Cardiovascular: Hypertension (5.3% to 7.3% ) Gastrointestinal: Abdominal pain (5.1% to 7.8% )， Diarrhea (2.4% to 6.8% )， Indigestion (3.6% to 11.9% )， Nausea (2.1% to 5.1% ) Musculoskeletal: Backache (4.3% to 13.5% ) Neurologic: Headache (2.6% to 6.5% ) Respiratory: Bronchitis (2.1% to 10% )， Upper respiratory infection (2% to 33.7% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ibandronate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

